Working… Menu

Clarithromycin,Lenalidomide and Dexamethasone for Relapsed/Refractory Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02986451
Recruitment Status : Withdrawn
First Posted : December 8, 2016
Last Update Posted : August 14, 2018
China Food and Drug Administration
Information provided by (Responsible Party):
wanghua, Sun Yat-sen University

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : December 2019